Finding Common Ground With Our MASQs Off
- PMID: 33982962
- PMCID: PMC8127609
- DOI: 10.14309/ajg.0000000000001048
Finding Common Ground With Our MASQs Off
Conflict of interest statement
Conflicts of interest: Elliot Tapper has served as a consultant to Norvartis, Axcella, and Allergan, has served on advisory boards for Mallinckrodt, Bausch Health, Kaleido, Takea, Novo Nordisk, and has received unrestricted research grants from Gilead and Valeant.
Comment on
-
Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis.Am J Gastroenterol. 2020 Dec;115(12):2017-2025. doi: 10.14309/ajg.0000000000000762. Am J Gastroenterol. 2020. PMID: 32773463 Free PMC article.
-
MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?Am J Gastroenterol. 2021 Apr;116(4):836-837. doi: 10.14309/ajg.0000000000001010. Am J Gastroenterol. 2021. PMID: 33982961 No abstract available.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
